Why the study?
Does an initial hsTnT <5ng/L safely rule out acute coronary syndrome in patients with an interpretable EKG undergoing early treadmill stress testing?
Observational (n=274)
Does an initial hsTnT <5ng/L safely rule out acute coronary syndrome in patients with an interpretable EKG undergoing early treadmill stress testing?
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The conclusion for both clinicians and patients at high-risk of CV death post-MI is clear: Treatment with Brilinta 60mg, either as continuation therapy after the initial 12 month post-event period, or with as limited interruption as possible, is associated with a clear and favourable benefit-risk ratio for this population of patients. This new insight is potentially practice-changing, as while more than seven million people worldwide suffer a heart attack each year, we know that fewer than half receive adequate long-term treatment to reduce their risk of further CV events.”
“These new insights are important, showing that the effectiveness of ticagrelor did not lessen over three years of treatment. This supports the benefit of continuing ticagrelor at a 60mg dose for patients who tolerate ticagrelor 90mg for the first 12 months after MI.”
“The PEGASUS-TIMI 54 trial demonstrated that the addition of ticagrelor to low-dose aspirin in patients with a prior heart attack significantly reduced the risk of dying from cardiovascular causes, having another heart attack, or having a stroke. While it's important that physicians tailor their treatment approach for each patient, these data speak to the clinically important benefit that can be gained when adding ticagrelor to the current standard therapy in a patient population at increased risk for recurrent cardiovascular events in the long-term.”
An initial hsTnT <5ng/L in patients with an interpretable EKG safely rules out ACS with a 100% negative predictive value at 1 month.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Dellborg et al. (2017) conducted an observational in Suspected acute coronary syndrome (n=274). Initial hsTnT <5ng/L was evaluated on ACS, revascularization or death (NPV 100%).
Synapse has enriched 10 related papers. Consider them for comparative context: